Yi-BinAlbertChenMD

Clinical Trials

• Tandem Auto-Allo Transplant for Lymphoma Start of enrollment: 2010 Aug 01

  Completed

  Phase 2

• High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma Start of enrollment: 2010 Jun 01

  Completed

  Phase 2

• Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis Start of enrollment: 2011 Jul 01

  Terminated

  Not Applicable

• Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant Start of enrollment: 2011 Aug 01

  Completed

  Phase 1

• Brentuximab Vedotin for Steroid Refractory GvHD Start of enrollment: 2012 Jul 01

  Completed

  Phase 1

• Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation Start of enrollment: 2012 Jul 01

  Completed

  Phase 2

• Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders Start of enrollment: 2012 Nov 01

  Recruiting

  Not Applicable

• Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant Start of enrollment: 2013 May 16

  Completed

  Phase 1

• Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML Start of enrollment: 2014 Feb 06

  Completed

  Phase 2

• Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD) Start of enrollment: 2013 Oct 01

  Terminated

  Phase 1

• Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102) Start of enrollment: 2013 Dec 16

  Completed

  Phase 2

• Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT Start of enrollment: 2014 Apr 01

  Terminated

  Phase 1

• Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) Start of enrollment: 2014 Aug 01

  Completed

  Phase 2

• Non Invasive Optical Imaging of WBC Count Start of enrollment: 2015 Sep 01

  Completed

  Not Applicable

• Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma Start of enrollment: 2017 May 01

  Withdrawn

  Phase 1, Phase 2

• Fecal Microbiota Transplantation After HSCT Start of enrollment: 2016 May 01

  Completed

  Early Phase 1

• Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation Start of enrollment: 2016 Nov 29

  Active, not recruiting

  Phase 2

• Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies Start of enrollment: 2022 Jun 21

  Active, not recruiting

  Phase 3

  Roles: Contact

• Join now to see all